Showing 1 - 10 of 11
Persistent link: https://www.econbiz.de/10012140282
Persistent link: https://www.econbiz.de/10003580279
Persistent link: https://www.econbiz.de/10010433644
Persistent link: https://www.econbiz.de/10011392471
Persistent link: https://www.econbiz.de/10009699804
Persistent link: https://www.econbiz.de/10011563790
Persistent link: https://www.econbiz.de/10010510067
We evaluate the welfare effects of differential pricing, voluntary licensing, and compulsory licensing in the Indian market for oral anti-diabetic (OAD) drugs. This market includes a new class of molecules called DPP-4 inhibitors, all of which are under patent protection in India. The Indian...
Persistent link: https://www.econbiz.de/10013035611
Persistent link: https://www.econbiz.de/10014317938
Persistent link: https://www.econbiz.de/10012874236